Correlation Between Pharvaris and UroGen Pharma
Can any of the company-specific risk be diversified away by investing in both Pharvaris and UroGen Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharvaris and UroGen Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharvaris BV and UroGen Pharma, you can compare the effects of market volatilities on Pharvaris and UroGen Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharvaris with a short position of UroGen Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharvaris and UroGen Pharma.
Diversification Opportunities for Pharvaris and UroGen Pharma
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Pharvaris and UroGen is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Pharvaris BV and UroGen Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on UroGen Pharma and Pharvaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharvaris BV are associated (or correlated) with UroGen Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of UroGen Pharma has no effect on the direction of Pharvaris i.e., Pharvaris and UroGen Pharma go up and down completely randomly.
Pair Corralation between Pharvaris and UroGen Pharma
Given the investment horizon of 90 days Pharvaris BV is expected to generate 0.73 times more return on investment than UroGen Pharma. However, Pharvaris BV is 1.37 times less risky than UroGen Pharma. It trades about 0.06 of its potential returns per unit of risk. UroGen Pharma is currently generating about 0.03 per unit of risk. If you would invest 1,090 in Pharvaris BV on September 2, 2024 and sell it today you would earn a total of 1,100 from holding Pharvaris BV or generate 100.92% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pharvaris BV vs. UroGen Pharma
Performance |
| Timeline |
| Pharvaris BV |
| UroGen Pharma |
Pharvaris and UroGen Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pharvaris and UroGen Pharma
The main advantage of trading using opposite Pharvaris and UroGen Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharvaris position performs unexpectedly, UroGen Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in UroGen Pharma will offset losses from the drop in UroGen Pharma's long position.| Pharvaris vs. Pmv Pharmaceuticals | Pharvaris vs. Eliem Therapeutics | Pharvaris vs. MediciNova | Pharvaris vs. PepGen |
| UroGen Pharma vs. Eliem Therapeutics | UroGen Pharma vs. Inhibrx | UroGen Pharma vs. Celcuity LLC | UroGen Pharma vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |